Edgar Romero-Sandoval to Antineoplastic Agents
This is a "connection" page, showing publications Edgar Romero-Sandoval has written about Antineoplastic Agents.
Connection Strength
0.889
-
Pennypacker SD, Fonseca MM, Morgan JW, Dougherty PM, Cubillos-Ruiz JR, Strowd RE, Romero-Sandoval EA. Methods and protocols for chemotherapy-induced peripheral neuropathy (CIPN) mouse models using paclitaxel. Methods Cell Biol. 2022; 168:277-298.
Score: 0.587
-
Lycan TW, Hsu FC, Ahn CS, Thomas A, Walker FO, Sangueza OP, Shiozawa Y, Park SH, Peters CM, Romero-Sandoval EA, Melin SA, Sorscher S, Ansley K, Lesser GJ, Cartwright MS, Strowd RE. Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer. Muscle Nerve. 2020 05; 61(5):587-594.
Score: 0.129
-
Alfonso Romero-Sandoval E, Molina C, Herrero JF. Enhancement of the analgesic activity of paracetamol and nitroparacetamol by the oral administration of all-trans retinoic acid. Neuropharmacology. 2006 Sep; 51(4):858-65.
Score: 0.100
-
Jacobs VL, Landry RP, Liu Y, Romero-Sandoval EA, De Leo JA. Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol. 2012 Feb; 14(2):119-31.
Score: 0.073